Fountil Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.58 Cr
- Paid Up Capital ₹ 2.58 Cr
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -75.77%
- Profit Growth 86.20%
- Ebitda -65.78%
- Net Worth 102.48%
- Total Assets -91.72%
About Fountil Life Sciences
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230MH2012PTC236746
-
Company No.
236746
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Oct 2012
-
Date of AGM
30 Sep 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Fountil Life Sciences Private Limited offer?
Fountil Life Sciences Private Limited offers a wide range of products and services, including Popular Category, Stomach Care.
Who are the key members and board of directors at Fountil Life Sciences?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jigar Shah
![]() |
Additional Director | 28-Nov-2021 | Current |
Jayesh Sutaria
![]() |
Director | 12-Oct-2012 | Current |
Financial Performance of Fountil Life Sciences.
Fountil Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 75.77% decrease. The company also saw a substantial improvement in profitability, with a 86.2% increase in profit. The company's net worth Soared by an impressive increase of 102.48%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Fountil Life Sciences?
In 2021, Fountil Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
![Placeholder for charges-related data](/Images/tcc-no-data-images/Charges.webp)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fountil Life Sciences?
Unlock and access historical data on people associated with Fountil Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Fountil Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fountil Life Sciences's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.